Human medicines European public assessment report (EPAR): Epixram, levetiracetam, Status: Application withdrawn

Human medicines European public assessment report (EPAR): GONAL-f, follitropin alfa, Date of authorisation: 20/10/1995, Revision: 27, Status: Authorised

Second European Medicines Agency (EMA) and IPFA - PPTA global bilateral meeting, European Medicines Agency, Amsterdam, the Netherlands, 12 November 2024

Table of decisions of labelling exemption requests falling under article 63 of Directive 2001/83/EC examined by the Quality Review of Documents (QRD) Group

Orphan designation: [Nle4, D-Phe7]-alfa-melanocyte stimulating hormone (afamelanotide) Treatment of erythropoietic protoporphyria, 08/05/2008 Expired

Records of data processing activity for of the EMA's historical archives and opening to the public

European Medicines Agency’s data protection notice for the processing of personal data contained in the Agency’s historical records selected for permanent preservation and opening to the public

Human medicines European public assessment report (EPAR): Darunavir Viatris (previously Darunavir Mylan), darunavir, Date of authorisation: 03/01/2017, Revision: 15, Status: Authorised

Human medicines European public assessment report (EPAR): Wegovy, semaglutide, Date of authorisation: 06/01/2022, Revision: 11, Status: Authorised

Human medicines European public assessment report (EPAR): Renvela, sevelamer carbonate, Date of authorisation: 09/06/2009, Revision: 29, Status: Authorised